
Drugs targeting zzso are rapidly being incorporated into cancer treatment zzso zzso was the first zzso agent to gain approval by the Food and Drug Administration and is now approved for use in five tumor zzso This brief review highlights important recent advances in our understanding of zzso and the patient populations in whom it may be most zzso 

zzso from early studies that led to approval of zzso for use in zzso zzso cancer and zzso lung cancer have been zzso Although zzso does not appear to prolong zzso survival in the zzso treatment of zzso cancer, phase II results in the zzso treatment of zzso cancer and breast cancer are zzso It may also have a role in maintenance therapy of zzso cancer and zzso cell lung zzso zzso is an important agent in the treatment of zzso zzso Although the safety profile of zzso in combination with zzso agents has not changed significantly, there may be excess risk associated with combined zzso zzso 

zzso has efficacy in a wide variety of zzso and fairly predictable zzso In addition to further exploration of the benefits of zzso in other tumor types, future research should focus on integration of zzso into patient selection and zzso 

